Literature DB >> 19380079

Life-threatening organ failure after lamotrigine therapy.

Lee P Ferguson1, Paul I Dargan, Joanne L Hood, Shane M Tibby.   

Abstract

We describe an 11-year-old girl with a seizure disorder who developed fever, rash, rhabdomyolysis, and multiorgan failure 2 weeks after commencing a transition from sodium valproate to lamotrigine therapy. To our knowledge, this patient represents the most severe life-threatening hypersensitivity lamotrigine reaction described in the pediatric literature. We recommend caution when prescribing lamotrigine to children on concomitant sodium valproate, and immediate discontinuation of lamotrigine and the provision of aggressive supportive care in patients with features of lamotrigine hypersensitivity.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19380079     DOI: 10.1016/j.pediatrneurol.2008.11.018

Source DB:  PubMed          Journal:  Pediatr Neurol        ISSN: 0887-8994            Impact factor:   3.372


  3 in total

1.  Myotoxicity Induced by Antiepileptic Drugs: Could be a Rare but Serious Adverse Event?

Authors:  Antonio Siniscalchi; Scott Mintzer; Giovambattista De Sarro; Luca Gallelli
Journal:  Psychopharmacol Bull       Date:  2021-11-03

2.  Bronchiolitis obliterans organising pneumonia associated with anticonvulsant hypersensitivity syndrome induced by lamotrigine.

Authors:  Hasan Ghandourah; Samarjeet Bhandal; Marie-Anne Brundler; Mary Noseworthy
Journal:  BMJ Case Rep       Date:  2016-01-29

3.  The safety and tolerability of newer antiepileptic drugs in children and adolescents.

Authors:  Saima Kayani; Deepa Sirsi
Journal:  J Cent Nerv Syst Dis       Date:  2012-03-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.